Kestra Advisory Services, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Kestra Advisory Services, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2022$179,399
-99.9%
29,850
-40.8%
0.00%0.0%
Q3 2022$147,147,000
+140040.0%
50,400
+187.9%
0.00%
+100.0%
Q2 2022$105,000–17,505–0.00%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders